News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Anastasia Makhanova, PhD

Dr Makhanova is an associate professor in the Department of Psychological Science at University of Arkansas.

Articles by Anastasia Makhanova, PhD

birth control

Importance of Monitoring Patients’ Hormonal Contraceptive Use

ByAnastasia Makhanova, PhD,Mikayla DM Joslin, MA,Summer Mengelkoch, PhD

April 21st 2026

Evidence links some hormonal contraceptives—especially in teens—to higher depression risk; see which types matter and how to monitor mood.

Latest Updated Articles

Importance of Monitoring Patients’ Hormonal Contraceptive Use
April 21st 2026

Trending on Psychiatric Times

Positive Topline Results From Phase 3 Emerge Study of DT120 ODT in Major Depressive Disorder

FDA Issues CRL for Cytisinicline for Smoking Cessation in Adults

Evaluating Transdermal Asenapine in Schizophrenia

Empowering Patients and Expanding Formulation Options in Schizophrenia Care